Julia Madsen - 04 Jun 2024 Form 4 Insider Report for STERIS plc (STE)

Role
Senior VP, Life Sciences
Signature
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Issuer symbol
STE
Transactions as of
04 Jun 2024
Net transactions value
$0
Form type
4
Filing time
06 Jun 2024, 16:33:57 UTC
Previous filing
05 Jun 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Award $0 +1,626 +20% $0.000000 9,671 04 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Award $0 +8,336 $0.000000 8,336 04 Jun 2024 Ordinary Shares 8,336 $251.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of June 4, 2024, 4,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025; 144 on October 1, 2025; 578 on June 1, 2026; 352 on June 2, 2026; 542 on June 4, 2026 and 542 on June 4, 2027.
F2 This option becomes exercisable as follows: 2,084 on June 4, 2025; 2,084 on June 4, 2026; 2,084 on June 4, 2027 and 2,084 on June 5, 2028.